Advertisement
U.S. markets closed

Stayble Therapeutics AB (4K4.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
0.0162-0.0008 (-4.71%)
At close: 03:36PM CET
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
Operating Expense
22,265
24,952
12,140
14,984
Operating Income
-22,265
-24,952
-12,140
-14,984
Net Non Operating Interest Income Expense
-163.328
5.672
-28.071
-396.168
Pretax Income
-22,008
-24,526
-12,090
-15,487
Net Income Common Stockholders
-22,008
-24,526
-12,090
-15,487
Diluted NI Available to Com Stockholders
-22,008
-24,526
-12,090
-15,487
Basic EPS
-1.01
-1.72
-0.85
-1.74
Diluted EPS
-1.01
-1.72
-0.85
-1.74
Basic Average Shares
31,721
14,228
14,228
8,926
Diluted Average Shares
31,721
14,228
14,228
8,926
Total Operating Income as Reported
-22,109
-24,796
-12,140
-14,925
Total Expenses
22,265
24,952
12,140
14,984
Net Income from Continuing & Discontinued Operation
-22,008
-24,526
-12,090
-15,487
Normalized Income
-22,008
-24,526
-12,090
-15,487
Interest Income
-239.386
33.614
29.019
0
Interest Expense
-76.058
27.942
57.09
396.168
Net Interest Income
-163.328
5.672
-28.071
-396.168
EBIT
-22,084
-24,498
-12,033
-15,091
EBITDA
-22,084
-24,498
-12,033
-15,091
Net Income from Continuing Operation Net Minority Interest
-22,008
-24,526
-12,090
-15,487
Normalized EBITDA
-22,084
-24,498
-12,033
-15,091
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0